Back to AL Alphabet Inc.

LYELLYEL
5 quarters

Position history for ALAlphabet Inc.'s holdings in LYELL IMMUNOPHARMA INC

Yes. Alphabet holds 293,256 shares of LYEL (Lyell Immunopharma), worth $4.1M, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. Alphabet has held LYEL in every 13F on record since Q2 2025, 5 quarterly filings.

Current Value

$4.1M

Current Shares

293,256

Total Value Change

+$1.5M

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
293,256
0.0%
$4.1M0.0%$14.05
0
2026-Q1
Unchanged
293,256
0.0%
$5.9M0.1%$23.33
0
2025-Q4
Unchanged
293,256
0.0%
$9M0.3%$31.59
0
2025-Q3
Unchanged
293,256
0.0%
$4.8M0.2%$14.97
0
2025-Q2
New
293,256
-
$2.6M0.1%$8.94
44

Other major holders of LYEL: VANGUARD GROUP INC, VANGUARD CAPITAL MANAGEMENT LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used